There is an increasing recognition that long-term voriconazole use is associated with accelerated sun-induced skin changes that include acute...doi:10.1016/j.bbmt.2014.11.147Goyal, Rakesh K.Voller, DebraGoyal, ManuSankaranarayan, KumarElsevier Inc.Biology of Blood & Marrow Transplantation...
The medical records for each case were reviewed by two or three physicians to confirm the aGVHD diagnosis and grading (according to the MAGIC criteria19). To avoid ambiguity, onset of aGVHD was uniformly defined as the day of initiating aGVHD treatment. After the physicians’ review, 16 cases...
1994 Consensus conference on acute GVHD grading Bone Marrow Transplant, 15 (1995), pp. 825-828 View in ScopusGoogle Scholar 25 R.J. Deans, A.B. Moseley Mesenchymal stem cells: biology and potential clinical uses Exp Hematol, 28 (2000), pp. 875-884 View in ScopusGoogle Scholar 26 C. ...
So overall, grade 0 is pretty straightforward, which means there’s none. Grade 4 is pretty obvious too, which is basically grade 4 of any of the major organs, and grades 2 and 3 are somewhere in the middle. If you spend some time looking at the grading, you understand why GVHD is ...
Therefore, they are expected to become a new target for the prevention and treatment of GVHD. Ruxolitinib is a selective JAK 1/2 inhibitor, which mainly inhibits the activity of JAK by competitively blocking the binding site of ATP on the catalytic subunit of the JAK1/2 domain; it has the...
In contrast, the grading proposed by the Minnesota group limits the overall grade IV aGvHD to skin and gut stage IV instead of skin and liver stage IV as proposed in the Keystone criteria [103]. Recently, the Mount Sinai Acute GvHD International Consortium (MAGIC) revised these criteria [2]...
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995, 15, 825–828. [Google Scholar] [PubMed] Rabenau, H.F.; Marianov, B.; Wicker, S.; Allwinn, R. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin ...
(aGVHD) is a life-threatening complication of allogeneic stem cell trans-plantation (SCT) mainly affecting the stem cellrecipient’s skin, liver, and/or gastrointestinal tract [1].Matching the stem cell donor and recipient for HLAsignificantly reduces the risk for aGVHD and chronicGVHD [2]. In...
Allogeneic hematopoietic stem cell transplantation is the only curative therapy for patients with myelodysplastic syndrome. Transplantation-associated thrombotic microangiopathy (TA-TMA) remains a cause of death after transplantation. This study assessed the risk factors of TA-TMA and established a predictio...
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995; 15: 825–828. CAS PubMed Google Scholar Download references Author information Authors and Affiliations Department of Paediatric Immunology,...